Loading clinical trials...
Loading clinical trials...
Translational Phase I Trial of Escalating Doses of 5-Chloro-2'-Deoxycytidine (CldC) With a Fixed Dose of Tetrahydrouridine Combined With a Fixed Dose of Cisplatin Concomitant With Definitive Radiation in Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
Conditions
Interventions
cisplatin
cytochlor
+2 more
Locations
1
United States
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Start Date
April 1, 2004
Primary Completion Date
July 1, 2007
Completion Date
July 1, 2007
Last Updated
December 15, 2016
NCT04585750
NCT07457346
NCT06636188
NCT07065630
NCT05526924
NCT07447050
Lead Sponsor
University of Miami
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions